Exelixis
EXEL
#1726
Rank
NZ$21.22 B
Marketcap
NZ$78.84
Share price
0.46%
Change (1 day)
19.06%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company